pharmaphorum

AUGUST 12, 2021

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The post Health insurer Excellus will not fund Alzheimer’s drug Aduhelm appeared first on.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Department of Veterans Affairs 98

Putting Patients First Blog

JANUARY 27, 2025

Coverage of Anti-Obesity Medications (AOMs) The NHC applauds CMS for aligning with the medical community and proposing to recognize obesity as a chronic disease and allow Medicare Part D coverage for AOMs. Below, we provide detailed comments and recommendations on key provisions of the proposed rule.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

PharmaShots

FEBRUARY 9, 2023

It includes various tests such as, visual acuity test (for clarity), visual field test (for peripheral vision), tonometry test (pressure in eyes), pupil response test (way of lights enter into eyes) Optical Coherence Tomography: A non-invasive retina imaging test that uses light waves to take high resolution cross-section pictures of retina.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Department of Veterans Affairs 40